SFS
KYNB

Sowell Financial Services’s Kyntra Bio KYNB Stock Holding History

Sowell Financial Services’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-92
Closed -$47K – 1259
2021
Q1 		$47K Sell
92
-20
-18% -$21.3K ﹤0.01% 1681
2020
Q4 		$104K Buy
112
+101
+918% +$106K ﹤0.01% 1138
2020
Q3 		$12K Buy
11
+3
+38% +$3.23K ﹤0.01% 1747
2020
Q2 		$8K Hold
8
– – ﹤0.01% 1757
2020
Q1 		$7K Sell
8
-1
-11% -$994 ﹤0.01% 1709
2019
Q4 		$10K Buy
9
+6
+200% +$6.13K ﹤0.01% 1683
2019
Q3 		$2K Buy
+3
New +$3.29K ﹤0.01% 2069

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sowell Financial Services's KYNB Position: Q2 2021 in Review

Sowell Financial Services sold out of Kyntra Bio (KYNB) in Q2 2021, closing a stake of 92 shares — an estimated $47K sold.

Sowell Financial Services first reported a position in KYNB in Q3 2019 and held it in 7 quarters. The position peaked at $104K in Q4 2020. 175 funds tracked by Wall St. Rank hold KYNB as of Q2 2021.

  • Sowell Financial Services reported no remaining Kyntra Bio position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 92 Kyntra Bio shares in Q2 2021, an estimated $47K.
  • Sowell Financial Services first reported a position in Kyntra Bio in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Kyntra Bio position peaked at $104K in Q4 2020.
  • 175 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.